Innovative Research
The innovative CRO company specialized in high-end in vitro models of neurodegenerative diseases and drug development
EVENTS
Announcement - December 18, 2019 : Neuro-Sys and Sciomics announce a collaboration to co-develop an unrivaled integrated preclinical solution in neurodegenerative disorders.
Check out the article here
NEURO-SYS IS ONE AMONG THE "TOP 10 BIOANALYTICAL SERVICES COMPANIES 2019"
Proud to announce that Neuro-Sys is one among the "Top 10 Bioanalytical Services Companies 2019" by Pharma Tech Outlook !
This is a great consecration for the Neuro-Sys team and the work they do with its clients.
COVID-19 - SERVICE CONTINUITY
We are closely monitoring the coronavirus outbreak to ensure the protection of our employees and to enable our delivery of services.
We have robust continuity plans in place to prepare for unforeseen events and to meet the needs of customers, employees and stakeholders who depend on us.
In all cases, we will comply with the Government’s requirements, which we are monitoring very closely.
Preclinical services
Neuro-Sys has developed specific preclinical in vitro models of CNS and PNS diseases to achieve high-quality efficacy pharmacology as well as mode of action studies, a unique cost-effective strategy to accurately determine the pharmacological profiling of lead compounds and explore their underlying mechanism of action. We provide studies to determine the neuroprotective activity of lead compounds but also of dietary supplements and medical nutrition.
We are dedicated to providing high-level technical expertise and preclinical CRO services in a collaborative relationship with our clients, mainly focusing on :
› Alzheimer’s disease (AD)
› Parkinson’s disease (PD)
› Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease)
› Multiple Sclerosis (MS)
› Peripheral Neuropathies
NEURO-SYS HAS BEEN AWARDED "BEST INTERNATIONAL DRUG DEVELOPMENT AND DISCOVERY DEVELOPMENT COMPANY, 2019" BY GHP !
(SPE)
(natural or chemical source)
Drug discovery
Neuro-Sys is developing a pipeline of innovative compounds focused on treatments for neurodegenerative diseases, orphan diseases and auto-immune diseases, both internally and through collaborations. We identify our lead compounds using our innovative and cutting-edge technology platform, including our internal manufacturing process.
13120 GARDANNE - FRANCE
info@neuro-sys.com
+33 (0)4 13 41 51 71
+33 (0)4 13 41 51 72
BOSTON MA 02109 - USA
info@neuro-sys.com
+1 617-588-3257